PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 12, 2005 Subscribe to this News Feed    
 

Amazing New Weightloss Discovery Now Available for the First Time - Natural Fiber Creates Weight Loss When Simply Taken with Meals

Impressive new weight loss breakthrough reall works. New soluble fiber promotes weight loss when take with meals. Published clinical studies and ongoing research show up to 42 lbs weight loss with no change in diet. Educational info at Artjen.net

(PRWEB) September 12, 2005 -- A new and different weight loss discovery has now received all required Federal regulatory approvals and is available for the first time. The new invention works well in obese individuals and for people with diabetes who need to lose weight.

George Grunberger, M.D., of the renowned Grunberger Diabetes Institute in Michigan has just completed clinical trials of the new product called FBCx, the Fat Binding Complex. Important conclusions to the Clinical Study include:

 
  • FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.
  • FBCx is effective in reducing blood lipid levels in patients with hypertriglyceridemia. Commonly called 'elevated blood triglycerides.
  • FBCx can be easily incorporated into diabetes management regimen.
  • FBCx was shown to bind 9.7 times its own weight in dietary fat in patients with type 2 diabetes that do not require insulin therapy.

Dr Grunberger states that: About 90 % of folks with type 2 diabetes are obese and obesity is the number 2 preventable cause of death in the U.S." Until this new discovery, FBCx, There was no known effective way to keep weight off." Said Dr Grunberger This discovery, which can help shed pounds or prevent weight gain is real progress."

The co-inventors of FBCx are professors Joe Artiss, Ph.D. and Cathy Jen, Ph.D. both of Wayne State University in Detroit, Michigan. FBCx is the first new approach to weight loss, effective for diabetics and others" said Dr Artiss. Dr Jen said Unlike claims made by others before, this product actually works." Dr Artiss, who lives in Canada, points out the FBCx weight loss discovery is available in Canada as well as throughout the United States.

The important results of this first published clinical trial could change the face of dietary management in patients with type 2 diabetes. Subjects in pre clinical trials, including non diabetic patients showed dramatic and consistent weight loss. Many reported significant weight loss in the first few weeks and up to 40 pounds over time. Results of full clinical trials were presented at the American Diabetes Association meeting in San Diego, California June 10 through 14.
                  
Employing a natural fiber, fat in the diet is efficiently locked out of the digestive process. Each 1 gram tablet binds 9 grams of fat effectively blocking that fat from absorption by the body. Dr. Artiss said: Theres too much information to go into detail here but theres full scientific information available at the educational website we set up: ArtJen.net.

Taking the recommended 2 tablets per typical North American meal results in a weight loss of 1 to 1½ pounds loss per week. The product is now available under the FBCx name which stands for Fat Binding Complex. A US patent has been awarded to the ArtJen Company for FBCx. Detailed information , as well as product availability, is now available for the first time at the educational website ArtJen.net

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Jason Farlam
ARTJEN COMPLEXUS HOLDINGS CORP.
519-980-3013
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.